首页> 中文期刊> 《实用检验医师杂志》 >原发性肝癌患者炎性细胞因子检测的临床诊断价值

原发性肝癌患者炎性细胞因子检测的临床诊断价值

         

摘要

目的:探讨白介素6(interleukin-6, IL-6)、IL-1β、IL-10、IL-17、肿瘤坏死因子α(tumor necrosis factorα, TNF-α)及IL-27在原发性肝癌患者血清中的水平及其与肝癌发生和转移的关系。方法收集我院2012年1月-2014年12月确诊的原发性肝癌患者100例,分为无转移组48例和肝转移组52例,采用Luminex xMAP技术检测血清细胞因子IL-6、IL-1β、IL-10、IL-17、TNF-α及IL-27,并对数据进行统计分析。结果肝转移组患者IL-17和IL-27水平均显著高于无转移组,差异均有统计学意义(P均<0.05)。肝转移组患者中,仅IL-17与IL-1β呈正相关(r=0.275,P=0.048)。受试者工作特征曲线分析结果显示,IL-17和IL-27诊断肝癌转移的曲线下面积分别为0.664和0.818,最佳诊断cutoff值分别为2.005 pg/mL和238.95 pg/mL,敏感性分别为83.3%和98.5%,特异性分别为35.7%和64.3%,阳性预测值分别为58.1%和62.1%,阴性预测值分别为43.4%和44.4%,约登指数分别为35.7和62.8。结论 IL-17和IL-27均为促进肝癌细胞生长的细胞因子,可作为预测肝癌转移及预后的有效指标。 IL-27对诊断肝癌转移的临床诊断性能指标水平均高于IL-17,对肝癌早期转移的诊断价值更好。%Objective To investigate the levels of IL-6, IL-1β, IL-10, IL-17, TNF-αand IL-27 in the serum of patients with primary hepatocellular carcinoma , and to explore their relationship with hepato-cellular carcinoma. Methods 100 hepatocellular carcinoma patients were collected from January 2012 to De-cember 2014 in our hospital, which were divided into non-metastasis group (48 cases) and hepatic metastasis group(52 cases). All cytokines were detected by Luminex xMAP technology, and all data were analyzed statis-tically. Results Levels of IL-17 and IL-27 in hepatic metastasis group were all higher than that of non-metastasis group, and the differences all had statistical significance (Pall<0.05). In hepatic metastasis group, only IL-17 and IL-1βhad positive correlation (r=0.275,P=0.048). Receiver operating characteristic curve showed that the area under the curve of IL-17 and IL-27 detection of hepatocellular carcinoma metastasis was 0.664 and 0.818, respectively. And the cutoff value were 2.005 pg/mL and 238.95 pg/mL. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and Youden index of IL-17 de-tection of hepatic metastasis were 83.3%, 35.7%, 58.1%, 43.4% and 35.7, respectively. The sensitivity, specificity, PPV, NPV and Youden index of IL-27 detection of hepatic metastasis were 98.5%, 64.3%, 62.1%, 44.4%and 62.8, respectively. Conclusion IL-17 and IL-27 are cytokines which promote occur-rence, development and metastasis of hepatocellular carcinoma. IL-17 and IL-27 can be used as effective pre-dictors of liver cancer metastasis and prognosis. The clinical diagnosis of performance indicators levels of IL-27 in hepatocellular carcinoma are all higher than that of IL-17 , which has better diagnosis value to the early metastasis of hepatocellular carcinoma.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号